| Tag | Content |
|---|
EnhancerAtlas ID | HS162-04545 |
Organism | Homo sapiens |
Tissue/cell | Plasma_cell_myeloma |
Coordinate | chr17:80290420-80291570 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| MAFG | MA0659.1 | chr17:80290883-80290904 | TTACTGCGGAGTCAGCAAAAC | - | 6.39 | | MAFG | MA0659.1 | chr17:80290883-80290904 | TTACTGCGGAGTCAGCAAAAC | + | 6.53 | | MAFK | MA0496.2 | chr17:80290884-80290903 | TACTGCGGAGTCAGCAAAA | + | 6.56 | | MAFK | MA0496.2 | chr17:80290884-80290903 | TACTGCGGAGTCAGCAAAA | - | 6 | | Myog | MA0500.1 | chr17:80290481-80290492 | GACAGCTGCAG | + | 6.62 | | Tcf12 | MA0521.1 | chr17:80290481-80290492 | GACAGCTGCAG | + | 6.14 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_40455 | chr17:80289885-80291329 | K562 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | TCAGGGAACA CAGGTGACCC CACGTCTCTA CCGAGAATGA GCACACCAAC ACCTCTCAGA 60
AGACAGCTGC AGCCTGCAGA GGCCATGGAC CCCACCCAGG CCCACGGTGT GGACGGCTCT 120
GCCCTGGTCT CTGCTGAGCC AGGCCCAGAG GGGACCCCAG GTGAGCAGCA AAGCCCCCCA 180
GGCCTGGGGC TAGACCGGGC TAACCCTTCC TGCTCAGCAC CTGTTCACCT GTCCCCTCTG 240
CTGGTGGCCT CCTGTCCTCC CGCTCTGGGC TCAGCAGCAG CCCCGTGGAG AGGCCCTGCC 300
ACCACCCCCG CCCTGCTGGA GACAGGCCTC CTACGCGGGC TCCTGCAGCC GGTCGCCCTG 360
GGCCTCCTAG AAGCCGGGGA TCCTCTGCTG ACCACCGGCA GAAAACGTGC TTCTCAAGCT 420
GCAGGTGATT CACCAGTAGT GGGCAAGGAA CTGAATGTGG TGATTACTGC GGAGTCAGCA 480
AAACCCGCGT GAGAACGGGC AGCTGAGGGC CTGCCGGGTG AGGGAAGCCT CACGGTTCCT 540
GTTTCATGAG TTTGCTGTGA GTGCACACGA GGCTGTGGCT GTGGAGTGTG CAACAGTCCA 600
CGCGTGCCTG CGTGTGCTCA TGTGCGTGTG TCCACCAGCT TGTGTGCACG CATATGAGCG 660
AGTGCGTTTT GCTCCCAGCT TGGTCGCAGC GACGGCGCAG GGAACCCCGG GTGAGGCCGA 720
GGACCGGGAA GGGAGGAGGG GGCTCCGACC CATCGGACTT AGGGGAGCCC CGGGTCCGAG 780
ACGCCGCCTC TGTCCCTTCA AGAGTCGAGC CTGGCGCACA GGGCAGGGAC GCGGGTCCCC 840
ACACCGGCCG GCAGCTCGTT CCCGCCCATA CTCGGGTACG CCCGCTGCGA CCCCGCCCGC 900
CTGGCCTGCG ACGCACGCTC AGGGCCAGCG GGGGGTGACG GTCCCAGAGG CAGAGGCGCC 960
GCAGCCCCAG AGTCCCCATC CCTGCGCGGA CCGGCAACCC CAGTGCACCA AGAGGCCCTA 1020
ACACCGAGCC CCCAGCACCG AGTCCCCAGC ACCGGGCCCT CAGCACCGAG TCCCCAGCAC 1080
CGAGTCCCCA GCACCGAGTC CCCAGCACCG AGCCCGCCCC TCTGGTTCCC CCGCCCGCCC 1140
CTCTCCGCGC 1150
|
